An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The vaccine doesn't prevent cancer from happening in the first place, but an early-phase trial found it could reduce the odds ...

Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The ...

The new vaccine, which has shown promise in an early trial involving 20 pancreatic cancer patients and five with bowel cancer ...

A new experimental pancreatic cancer vaccine may help stop the disease from coming back. it targets common gene mutations found in about 90% of pancreatic cancers.

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival rates. The vaccine was tested in a phase 1 trial involving 20 pancreatic ...